LUYE PHARMA
021861.6352.97% ( -0.050 )
Financials
H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: LUYE PHARMA(02186) the Revenue is 3.468 B (-0.52%), Miss estimate;the EBIT is 438.01 M (-34.51%), Miss estimate;the EPS is 0.0296 (-67.57%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
3.47B0.52%
3.65B4.76%
-0.18B5.28%
EBITMiss expectations
0.44B34.51%
0.53B20.23%
-0.10B14.28%
EPSMiss expectations
0.029667.57%
0.057836.65%
-0.028230.92%
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 18, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly